EyePoint Pharmaceuticals Settles DEXYCU Case, Enhances Compliance OversightTip Ranks·Jul 17 at 04:34 PMEYPT-2.25%
This Rambus Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursdaybenzinga_article·Jul 16 at 06:46 AMEYPT-2.25%RMBS-6.96%
EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)Unusual Whales·Jul 16 at 06:03 AMEYPT-2.25%
EyePoint grants inducement stock options for 63,500 shares at $13.85 eachPUBT·Jul 16 at 06:03 AMEYPT-2.25%
9 Health Care Stocks With Whale Alerts In Today’s Sessionbenzinga_article·Jul 9 at 12:35 PMCAPR-0.66%LLY+0.86%
EyePoint Chief Medical Officer Ramiro Ribeiro disposes of 4,875 common shares worth $73,167.95PUBT·Jul 2 at 03:04 PMEYPT-2.25%
Will SpaceX Stock Double Anytime Soon? No -- but These 3 Stocks CouldMotley Fool·Jun 29 at 04:10 AMEYPT-2.25%ADMA-1.19%
EyePoint shareholders approve 4.9 million-share increase to 2023 incentive planPUBT·Jun 22 at 06:05 AMEYPT-2.25%
Analyst Reiterates Buy on EyePoint, Sees Durability as Key Differentiator with Price Target Maintained at $43Tip Ranks·Jun 11 at 06:45 PMEYPT-2.25%
EyePoint Pharmaceuticals Eyes Transformative 2026 as DURAVYU Phase 3 Data NearsMarket Beat·May 26 at 11:04 AMEYPT-2.25%XBI-1.15%
